ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high-risk resected NSCLC.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.tps9077
Abstract: TPS9077Background: ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial) is a clinical trial platform of the National Cancer Institute that offers biomarker analysi... read more here.
Keywords: alchemist; alchemist adjuvant; targeted therapy; adjuvant targeted ... See more keywords